TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cosmesis and Body Image After Single Port Laparoscopic or Conventional Laparoscopic Cholecystectomy: A Double Blinded Randomised Controlled Trial
Brief Summary: Laparoscopic Cholecystectomy (LC) is the treatment of choice for symptomatic gallstone disease. Single-port access cholecystectomy (SL) has been recently introduced using only one, trans-umbilical placed port. The method has been denominated as ''scarless.'' However, it is unknown whether SL significantly improves body and cosmesis images as well as the quality of life (QoL), reported directly by the patients. Furthermore SL promises to reduce postoperative pain and to be cost-effective due a faster postoperative recovery.

The aim of this Double Blind Randomized Controlled Trial (RCT) is to demonstrate whether SL is superior to LC in improving patients', body and cosmesis images as well as QoL and to analyse cost-efficiency.

Based on the sample size calculations, a total of 110 patients will be randomised to either LC or SL. The primary endpoint will be the cosmetic score. Costs, pain, time to convalescence, quality of life and complications and will also be compared as secondary endpoints.

This study will provide evidence-based patient-oriented information regarding the SL procedure and its further use.


Options:
A: Arm Label: 1; Type: OTHER; Interventions: Procedure: SPA cholecystectomy | Arm Label: 2; Type: OTHER; Interventions: Procedure: Laparoscopic cholecystectomy | Intervention Type: PROCEDURE; Name: SPA cholecystectomy; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Laparoscopic cholecystectomy; Assigned to Arm(s): 2
B: Arm Label: SILS Cholecystectomy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: SILS | Arm Label: Standard Laparoscopic Cholecystectomy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Standard Laparoscopic Cholecystectomy | Intervention Type: PROCEDURE; Name: SILS; Assigned to Arm(s): SILS Cholecystectomy | Intervention Type: PROCEDURE; Name: Standard Laparoscopic Cholecystectomy; Assigned to Arm(s): Standard Laparoscopic Cholecystectomy
C: Arm Label: Standard lap chole; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Standard laparoscopic cholecystectomy | Arm Label: Single incision lap chole; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Single incision laparoscopic cholecystectomy | Intervention Type: PROCEDURE; Name: Standard laparoscopic cholecystectomy; Assigned to Arm(s): Standard lap chole | Intervention Type: PROCEDURE; Name: Single incision laparoscopic cholecystectomy; Assigned to Arm(s): Single incision lap chole
D: Arm Label: Single Port Cholecystectomy; Type: EXPERIMENTAL; Interventions: Device: Single Port Cholecystectomy | Arm Label: 4 Port Cholecystectomy; Type: ACTIVE_COMPARATOR; Interventions: Device: 4 Port Cholecystectomy | Intervention Type: DEVICE; Name: Single Port Cholecystectomy; Assigned to Arm(s): Single Port Cholecystectomy | Intervention Type: DEVICE; Name: 4 Port Cholecystectomy; Assigned to Arm(s): 4 Port Cholecystectomy

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter, Double Blind Trial to Compare the Efficacy and Safety of Escitalopram With Placebo in Patients With Acute Stroke for the Prevention of Poststroke Depression and Related Symptoms (Emotional Incontinence, Anger Proneness), and for Improvement of Neurologic, Cognitive Function and Quality of Life
Brief Summary: Through this study, the investigators are to demonstrate the superiority of Escitalopram over placebo for the prevention of poststroke depression in patients with acute stroke

The primary hypothesis of this study is;

This study will prove the superiority of Escitalopram on the prevention of poststroke depression in patients with acute stroke against placebo


Options:
A: Arm Label: intravenous tissue plasminogen activator; Type: EXPERIMENTAL; Interventions: Drug: Alteplase | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Alteplase; Assigned to Arm(s): intravenous tissue plasminogen activator | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: escitalopram; Type: EXPERIMENTAL; Interventions: Drug: Escitalopram | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: sugar pill | Intervention Type: DRUG; Name: Escitalopram; Assigned to Arm(s): escitalopram | Intervention Type: DRUG; Name: sugar pill; Assigned to Arm(s): placebo
C: Arm Label: In-person behavioral intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Brief pleasurable events/behavioral therapy | Arm Label: Telephone behavioral intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Brief pleasurable events/behavioral therapy | Arm Label: Standard care; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard care | Intervention Type: BEHAVIORAL; Name: Brief pleasurable events/behavioral therapy; Assigned to Arm(s): In-person behavioral intervention, Telephone behavioral intervention | Intervention Type: OTHER; Name: Standard care; Assigned to Arm(s): Standard care
D: Arm Label: active rTMS treatment; Type: EXPERIMENTAL; Interventions: Device: active rTMS treatment | Arm Label: sham rTMS treatment; Type: SHAM_COMPARATOR; Interventions: Device: sham rTMS treatment | Intervention Type: DEVICE; Name: active rTMS treatment; Assigned to Arm(s): active rTMS treatment | Intervention Type: DEVICE; Name: sham rTMS treatment; Assigned to Arm(s): sham rTMS treatment

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter, Double Blind Trial to Compare the Efficacy and Safety of Escitalopram With Placebo in Patients With Acute Stroke for the Prevention of Poststroke Depression and Related Symptoms (Emotional Incontinence, Anger Proneness), and for Improvement of Neurologic, Cognitive Function and Quality of Life
Brief Summary: Through this study, the investigators are to demonstrate the superiority of Escitalopram over placebo for the prevention of poststroke depression in patients with acute stroke

The primary hypothesis of this study is;

This study will prove the superiority of Escitalopram on the prevention of poststroke depression in patients with acute stroke against placebo


Options:
A: Arm Label: Fluoxetine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fluoxetine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Fluoxetine; Assigned to Arm(s): Fluoxetine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: SSRI; Type: EXPERIMENTAL; Interventions: Drug: SSRI | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: SSRI; Assigned to Arm(s): SSRI | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: escitalopram; Type: EXPERIMENTAL; Interventions: Drug: Escitalopram | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: sugar pill | Intervention Type: DRUG; Name: Escitalopram; Assigned to Arm(s): escitalopram | Intervention Type: DRUG; Name: sugar pill; Assigned to Arm(s): placebo
D: Arm Label: 1 Problem Solving Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Problem Solving Therapy | Arm Label: 2. Escitalopram; Type: EXPERIMENTAL; Interventions: Drug: Escitalopram | Arm Label: 3 Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: BEHAVIORAL; Name: Problem Solving Therapy; Assigned to Arm(s): 1 Problem Solving Therapy | Intervention Type: DRUG; Name: Escitalopram; Assigned to Arm(s): 2. Escitalopram | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): 3 Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter, Double Blind Trial to Compare the Efficacy and Safety of Escitalopram With Placebo in Patients With Acute Stroke for the Prevention of Poststroke Depression and Related Symptoms (Emotional Incontinence, Anger Proneness), and for Improvement of Neurologic, Cognitive Function and Quality of Life
Brief Summary: Through this study, the investigators are to demonstrate the superiority of Escitalopram over placebo for the prevention of poststroke depression in patients with acute stroke

The primary hypothesis of this study is;

This study will prove the superiority of Escitalopram on the prevention of poststroke depression in patients with acute stroke against placebo


Options:
A: Arm Label: Dialogue-based psychosocial intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Dialogue-based psychosocial rehabilitation | Arm Label: Usual care Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dialogue-based psychosocial rehabilitation; Assigned to Arm(s): Dialogue-based psychosocial intervention
B: Arm Label: In-person behavioral intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Brief pleasurable events/behavioral therapy | Arm Label: Telephone behavioral intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Brief pleasurable events/behavioral therapy | Arm Label: Standard care; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard care | Intervention Type: BEHAVIORAL; Name: Brief pleasurable events/behavioral therapy; Assigned to Arm(s): In-person behavioral intervention, Telephone behavioral intervention | Intervention Type: OTHER; Name: Standard care; Assigned to Arm(s): Standard care
C: Arm Label: Sham Stimulation; Type: SHAM_COMPARATOR; Interventions: Device: Transcranial Direct Current Stimulation | Arm Label: Active Stimulation; Type: ACTIVE_COMPARATOR; Interventions: Device: Transcranial Direct Current Stimulation | Intervention Type: DEVICE; Name: Transcranial Direct Current Stimulation; Assigned to Arm(s): Active Stimulation, Sham Stimulation
D: Arm Label: escitalopram; Type: EXPERIMENTAL; Interventions: Drug: Escitalopram | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: sugar pill | Intervention Type: DRUG; Name: Escitalopram; Assigned to Arm(s): escitalopram | Intervention Type: DRUG; Name: sugar pill; Assigned to Arm(s): placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter, Double Blind Trial to Compare the Efficacy and Safety of Escitalopram With Placebo in Patients With Acute Stroke for the Prevention of Poststroke Depression and Related Symptoms (Emotional Incontinence, Anger Proneness), and for Improvement of Neurologic, Cognitive Function and Quality of Life
Brief Summary: Through this study, the investigators are to demonstrate the superiority of Escitalopram over placebo for the prevention of poststroke depression in patients with acute stroke

The primary hypothesis of this study is;

This study will prove the superiority of Escitalopram on the prevention of poststroke depression in patients with acute stroke against placebo


Options:
A: Arm Label: escitalopram; Type: EXPERIMENTAL; Interventions: Drug: Escitalopram | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: sugar pill | Intervention Type: DRUG; Name: Escitalopram; Assigned to Arm(s): escitalopram | Intervention Type: DRUG; Name: sugar pill; Assigned to Arm(s): placebo
B: Arm Label: Fluoxetine; Type: EXPERIMENTAL; Interventions: Drug: Fluoxetine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Fluoxetine; Assigned to Arm(s): Fluoxetine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: 1 Problem Solving Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Problem Solving Therapy | Arm Label: 2. Escitalopram; Type: EXPERIMENTAL; Interventions: Drug: Escitalopram | Arm Label: 3 Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: BEHAVIORAL; Name: Problem Solving Therapy; Assigned to Arm(s): 1 Problem Solving Therapy | Intervention Type: DRUG; Name: Escitalopram; Assigned to Arm(s): 2. Escitalopram | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): 3 Placebo
D: Arm Label: Selective Serotonin Reuptake Inhibitors; Type: ACTIVE_COMPARATOR; Interventions: Drug: Citalopram | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Citalopram; Assigned to Arm(s): Selective Serotonin Reuptake Inhibitors | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Trial to Investigate the Impact of a Low Glycemic Index (GI) Diet on Body Mass Index and Obesity Related Cardiovascular and Hormonal Factors in Chinese Adolescents
Brief Summary: Epidemiological studies suggest a role for a low glycemic index (GI) diet in the management of obesity and associated metabolic risks including diabetes. However, evidence from long-term, randomized controlled trials exploring the relationship between low GI diet, weight reduction and glycemia, particularly in children and adolescents, is lacking. Modern food-processing technology has produced many food products with high GI which may contribute to the burgeoning epidemic of obesity worldwide. Since dietary habits are shaped in early life, adolescence is a critical period to educate our young people to acquire a healthy eating habit to prevent obesity.

The investigators hypothesized that, in Chinese adolescents, low GI diet results in greater reduction in body mass index and body fat percentage, enhanced insulin sensitivity and favorable changes of cardiometabolic risk factors compared to conventional diet after 12 months of intervention.

This study is a randomized controlled trial of a low GI (\<55) versus conventional Chinese diet (GI\>/=70) in adolescents (12-month intervention followed by a 6-month observational period) to study; 1) the changes in body mass index and obesity associated changes in cardiometabolic profile; 2) the underlying hormonal factors associated with these changes.


Options:
A: Intervention Type: BEHAVIORAL; Name: Low glycemic index diet; Assigned to Arm(s): N/A
B: Intervention Type: BEHAVIORAL; Name: weight management program; Assigned to Arm(s): N/A
C: Arm Label: W82GO; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: W82GO | Arm Label: Smartphone; Type: EXPERIMENTAL; Interventions: Device: smartphone application | Intervention Type: BEHAVIORAL; Name: W82GO; Assigned to Arm(s): W82GO | Intervention Type: DEVICE; Name: smartphone application; Assigned to Arm(s): Smartphone
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Reduction of sugar-sweetened beverage consumption | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Reduction of sugar-sweetened beverage consumption; Assigned to Arm(s): 1

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Study of Treatment of Dyslipidemia for Hemodialysis
Brief Summary: The purpose of this study is to determine Effect of oral L-carnitine supplement on lipid profile, anemia, and quality of life.


Options:
A: Arm Label: UCR; Type: ACTIVE_COMPARATOR; Interventions: Device: UCR | Arm Label: UTR; Type: ACTIVE_COMPARATOR; Interventions: Device: UTR | Arm Label: conventional dialysis; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: UCR; Assigned to Arm(s): UCR | Intervention Type: DEVICE; Name: UTR; Assigned to Arm(s): UTR
B: Arm Label: Oral nutritional supplement with probiotics; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Oral nutritional supplement with probiotics | Arm Label: Oral nutritional supplement without probiotics; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Oral nutritional supplement without probiotics | Arm Label: Individualized dietary recommendations; Type: ACTIVE_COMPARATOR; Interventions: Other: Dietary recommendations | Intervention Type: DIETARY_SUPPLEMENT; Name: Oral nutritional supplement with probiotics; Assigned to Arm(s): Oral nutritional supplement with probiotics | Intervention Type: DIETARY_SUPPLEMENT; Name: Oral nutritional supplement without probiotics; Assigned to Arm(s): Oral nutritional supplement without probiotics | Intervention Type: OTHER; Name: Dietary recommendations; Assigned to Arm(s): Individualized dietary recommendations
C: Arm Label: placebo; Type: OTHER; Interventions: Drug: placebo | Arm Label: L-carnitine; Type: OTHER; Interventions: Drug: L-carnitine | Intervention Type: DRUG; Name: L-carnitine; Assigned to Arm(s): L-carnitine | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo
D: Arm Label: Glucose solution; Type: ACTIVE_COMPARATOR; Interventions: Drug: PD solution containing glucose | Arm Label: Glucose and L-carnitine solution; Type: EXPERIMENTAL; Interventions: Drug: PD solution containing glucose and L-carnitine | Intervention Type: DRUG; Name: PD solution containing glucose; Assigned to Arm(s): Glucose solution | Intervention Type: DRUG; Name: PD solution containing glucose and L-carnitine; Assigned to Arm(s): Glucose and L-carnitine solution

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cervical Foley Plus Vaginal Misoprostol Versus Vaginal Misoprostol for Cervical Ripening and Labor Induction: A Randomized Trial
Brief Summary: The purpose of this study is to compare the efficacy of the combination of the supracervical foley bulb and vaginal misoprostol to vaginal misoprostol alone for labor induction. We hypothesize that use of the foley bulb plus vaginal misoprostol will result in shorter induction to delivery time.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: Induction of labor with foley balloon - 60cc of saline | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Induction of labor with foley balloon with 30cc | Intervention Type: PROCEDURE; Name: Induction of labor with foley balloon - 60cc of saline; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Induction of labor with foley balloon with 30cc; Assigned to Arm(s): 2
B: Arm Label: Foley Bulb plus Misoprostol; Type: EXPERIMENTAL; Interventions: Device: Foley bulb | Arm Label: Misoprostol; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Foley bulb; Assigned to Arm(s): Foley Bulb plus Misoprostol
C: Arm Label: misoprostol group; Type: ACTIVE_COMPARATOR; Interventions: Device: misoprostol | Arm Label: misoprostol and foley bulb group; Type: ACTIVE_COMPARATOR; Interventions: Device: misoprostol, Device: Foley bulb | Intervention Type: DEVICE; Name: misoprostol; Assigned to Arm(s): misoprostol and foley bulb group, misoprostol group | Intervention Type: DEVICE; Name: Foley bulb; Assigned to Arm(s): misoprostol and foley bulb group
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Device: Foley catheter | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Device: Atad catheter | Intervention Type: DEVICE; Name: Foley catheter; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: Atad catheter; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cervical Foley Plus Vaginal Misoprostol Versus Vaginal Misoprostol for Cervical Ripening and Labor Induction: A Randomized Trial
Brief Summary: The purpose of this study is to compare the efficacy of the combination of the supracervical foley bulb and vaginal misoprostol to vaginal misoprostol alone for labor induction. We hypothesize that use of the foley bulb plus vaginal misoprostol will result in shorter induction to delivery time.


Options:
A: Arm Label: Oxytocin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxytocin | Arm Label: Foley Catheter and Oxytocin; Type: EXPERIMENTAL; Interventions: Device: Foley Catheter, Drug: Oxytocin | Intervention Type: DEVICE; Name: Foley Catheter; Assigned to Arm(s): Foley Catheter and Oxytocin | Intervention Type: DRUG; Name: Oxytocin; Assigned to Arm(s): Foley Catheter and Oxytocin, Oxytocin
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: misoprostol | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: dinoprostone | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Device: Bard Catheter (balloon catheter) | Intervention Type: DRUG; Name: misoprostol; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: dinoprostone; Assigned to Arm(s): 2 | Intervention Type: DEVICE; Name: Bard Catheter (balloon catheter); Assigned to Arm(s): 3
C: Arm Label: Nulliparous - Foley only; Type: ACTIVE_COMPARATOR; Interventions: Device: Transcervical Foley catheter | Arm Label: Nulliparous - Foley and oxytocin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxytocin, Device: Transcervical Foley catheter | Arm Label: Multi(primi)parous - Foley only; Type: ACTIVE_COMPARATOR; Interventions: Device: Transcervical Foley catheter | Arm Label: Multi(primi)parous - Foley and oxytocin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxytocin, Device: Transcervical Foley catheter | Intervention Type: DRUG; Name: Oxytocin; Assigned to Arm(s): Multi(primi)parous - Foley and oxytocin, Nulliparous - Foley and oxytocin | Intervention Type: DEVICE; Name: Transcervical Foley catheter; Assigned to Arm(s): Multi(primi)parous - Foley and oxytocin, Multi(primi)parous - Foley only, Nulliparous - Foley and oxytocin, Nulliparous - Foley only
D: Arm Label: Foley Bulb plus Misoprostol; Type: EXPERIMENTAL; Interventions: Device: Foley bulb | Arm Label: Misoprostol; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Foley bulb; Assigned to Arm(s): Foley Bulb plus Misoprostol

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: EFFECTIVENESS OF A MULTIFACTORIAL INTERVENTION PROGRAM TO REDUCE FALLS INCIDENCE AMONG COMMUNITY-LIVING ELDERLY PEOPLE
Brief Summary: The purpose of this study is to determine the effectiveness of a multifactorial intervention program to prevent falls among the elderly as compared to a brief intervention.


Options:
A: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Treated group; Type: EXPERIMENTAL; Interventions: Other: Telephone support, telemonitoring and tele-exercise | Intervention Type: OTHER; Name: Telephone support, telemonitoring and tele-exercise; Assigned to Arm(s): Treated group
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Fall prevention course | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Fall prevention course; Assigned to Arm(s): 1
C: Arm Label: Multifactorial intervention; Type: EXPERIMENTAL; Interventions: Device: multifactorial | Intervention Type: DEVICE; Name: multifactorial; Assigned to Arm(s): Multifactorial intervention
D: Arm Label: nutritional and physical rehabilitation plan; Type: EXPERIMENTAL; Interventions: Behavioral: nutritional and a rehabilitation plan. | Intervention Type: BEHAVIORAL; Name: nutritional and a rehabilitation plan.; Assigned to Arm(s): nutritional and physical rehabilitation plan

Answer: C